We analyzed the associations of FTO and CEA, as well as CYFRA21-1, with clinical data of NSCLC patients and assigned them into corresponding high and low expression groups in the light of the median expression of the three. The gene discussed is FTO; the disease is non-small cell lung carcinoma.